Navigation Links
Nation's First of its Kind Consumer Medication Return Initiative Creates Momentum for Safe Drug Disposal in the U.S.
Date:5/8/2008

The University of Wisconsin-Extension, the Wisconsin Department of National

Resources and Capital Returns, Inc., a GENCO Supply Chain Solutions' Company, bring drug safety issues to the forefront with the launch of a

safe consumer medicine return trial.

PITTSBURGH, May 8 /PRNewswire/ -- Get the Meds Out, a consumer medication return pilot program, is set to launch this week with more than 500,000 potential participants in a two-county area in Wisconsin. The pioneering initiative, a joint effort between the University of Wisconsin - Extension (UWEX), the Wisconsin Department of Natural Resources (DNR) and Capital Returns, Inc. (CRI), promises to provide a safe drug disposal alternative to the local community while bringing national attention to drug safety issues affecting the public and the environment.

A research report published by the U.S. Geological Survey, determined that pharmaceuticals have been detected in multiple waterways in the U.S. This report puts a spotlight on the growing concern that improper disposal of pharmaceuticals is negatively impacting our environment.

"It is yet unclear what effect pharmaceuticals in the environment may have on humans, but it is clear that some aquatic species have been adversely affected," says Joanie Burns, Chief of the DNR's Hazardous Waste Prevention and Management Section. "Regardless, anything that can be done to prevent pharmaceuticals from entering into the environment in the first place is something we should all support."

The federal government, through its Office of National Drug Control Policy, issued federal guidelines for proper disposal of unused medications through household solid waste methods; however, these still include a reference to flushing some unused medications, and a national uniform program still does not exist for households to dispose of unwanted pharmaceutical products.

Even so, the concept of a unified medication return program has been on the table at CRI, the pharmaceutical industry's leading processor of pharmaceutical returns, for years. When the company was invited to present a mail-back consumer medicine return model at the 2006 International Unused Drug Conference in Portland Maine, it was a golden opportunity to accelerate and fine-tune details of their process, which uses reverse distributors to properly dispose of outdated and unused medicine.

"We are in the business of safe drug disposal for leading retailers and manufacturers in the pharmaceutical industry and a program tailored for the public has been on our agenda for some time," says Mary Hendrickson, Director of Quality and Regulatory Affairs for CRI and a registered pharmacist. "The challenge was to design a simple way for the public to get their unused medication to us for safe disposal and we were pleased when our medicine mail-back program became a reality through this pilot."

With newfound enthusiasm, Ms. Hendrickson and CRI brought the model back to Wisconsin and together with UWEX, created an ad-hoc group of individuals charged with addressing consumer pharmaceutical waste in the state. The group, led by Steve Brachman, Waste Reduction Specialist for UWEX, included Waukesha and Winnebago County recycling managers and other local county solid waste officials as well as representatives from the EPA, Illinois Indiana Sea Grant program, Wisconsin DNR and CRI. By early 2008 funding was secured to administer a pilot program and work began to assemble partners to help with awareness and execution.

Under the pilot program, consumers residing in the two counties will be able to call a special 800 number (1-800-958-5859) to receive instructions and a pre-paid shipping label. CRI, a company licensed as a reverse pharmaceutical distributor, will handle the calls and provide a return authorization and send out a pre-paid label for the old or unused medications, excluding controlled substances. This process allows CRI staff to personally explain the process. Once residents receive their pre-paid labels, they place their old medicine in a container for delivery back to CRI. Products received by CRI will be processed, separated into appropriate waste categories and then disposed of through incineration. The entire process is free to consumers.

"This was a team effort with the whole community embracing this initiative," says Mr. Brachman. "Because of the cooperation of so many, we're able to pull it all together and secure numerous retail business partners to assist in spreading the word to the public."

As the U.S. Drug Enforcement Agency begins its attempt to modify regulations that would potentially clear the way for more national and statewide drug take-back programs, the significance of this first of its kind pilot is already being established.

"The word is out and we are attracting attention and several serious inquiries for similar programs from around the country," says Ms. Hendrickson. Mr. Brachman adds, "This pilot and the buzz it is creating will only help advance consumer understanding of the issue and ease the creation of a medication return program in the future.

For more information, visit http://www.capitalreturns.com.


'/>"/>
SOURCE GENCO
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Haunted by hallucinations: Children in the PICU traumatized by delusions
2. American Red Cross Launches New Interactive Website to Connect NASCAR Fans With Blood Donations
3. United Nations Environment Programme and Bayer Corporation Announce North American Winners of International Childrens Painting Competition
4. American Red Cross Launches National Campaign to Connect NASCAR Fans With Blood Donations
5. Dubai Cares Announces 12 Country Plan to Educate and Empower Children in Developing Nations
6. Wanted: Illinois Family Physician of the Year Nominations
7. Parents Follow Pediatrician Advice on MMR Vaccinations
8. Tax Season Reminder: Vehicle Donations Still Needed
9. Nominations for Outstanding Cancer Survivor Award Being Accepted by Karmanos Cancer Institute Through April 27
10. Parents follow pediatrician advice on administering MMR vaccinations
11. Blue Cross and Blue Shield of Illinois Announces 2007 Charitable Donations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... ... January 19, 2017 , ... Wells Pharmacy Network ... of their 503A compounding pharmacy located in Ocala, Florida. , Meeting the ... patients throughout the United States for high-quality human anti-aging and wellness compounded ...
(Date:1/19/2017)... ... January 19, 2017 , ... LabRoots ... scientists from around the world, announces the launch of its newly redesigned website. ... portal to research breakthroughs and trending news, vital information on upcoming virtual events ...
(Date:1/19/2017)... ... January 19, 2017 , ... Cosmetic Town, an online plastic ... in order to make it easier for their readers to get the information they ... impact as well as the techniques used on those particular areas. , “We are ...
(Date:1/19/2017)... ... January 19, 2017 , ... Dr. ... of Dermatology and fellowship trained Mohs and cosmetic surgeon. After extensive dermatology research ... Li completed his internship in internal medicine at the Emory University and dermatology ...
(Date:1/19/2017)... ... January 19, 2017 , ... ... who administered fillers that resulted in severe facial disfiguration. After four frightening years ... by doctors at UCLA Medical Center, who removed the substances in a partial ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... 19, 2017 Report Details What ... areas are going to grow at the fastest rates? ... assessing data, trends, opportunities and prospects. Our 190-page ... most lucrative areas in the industry and the future ... sales across the all the major categories of the ...
(Date:1/19/2017)... , Jan. 19, 2017 Report Details ... ... for Leading Companies – our new study reveals trends, ... issues and events affecting the Alzheimer,s disease therapeutics and ... answer these key questions: - How is the Alzheimer,s ...
(Date:1/19/2017)... Incretin Mimetics/GLP-1 Agonists, SNDRIs, Lipase Inhibitors, Serotonin Receptor Agonists, ... anti-obesity drugs market is expected to grow at a CAGR ... CAGR of 38.7% in the second half of the forecast period. ... from 2016 to 2027. The market is estimated at $1,058 million ... ...
Breaking Medicine Technology: